1. Home
  2. QURE vs NHC Comparison

QURE vs NHC Comparison

Compare QURE & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$22.42

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

HOLD

Current Price

$236.53

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
NHC
Founded
1998
1971
Country
Netherlands
United States
Employees
248
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.5B
IPO Year
2013
1997

Fundamental Metrics

Financial Performance
Metric
QURE
NHC
Price
$22.42
$236.53
Analyst Decision
Strong Buy
Analyst Count
13
0
Target Price
★ $61.24
N/A
AVG Volume (30 Days)
★ 2.5M
78.4K
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
★ 1.10%
EPS Growth
★ 29.67
17.46
EPS
N/A
★ 4.82
Revenue
$13,107,000.00
★ $1,517,781,000.00
Revenue This Year
$54.78
N/A
Revenue Next Year
$356.14
N/A
P/E Ratio
★ N/A
$50.38
Revenue Growth
N/A
★ 16.09
52 Week Low
$8.73
$118.14
52 Week High
$71.50
$248.20

Technical Indicators

Market Signals
Indicator
QURE
NHC
Relative Strength Index (RSI) 28.08 53.97
Support Level $22.32 $216.83
Resistance Level $25.61 N/A
Average True Range (ATR) 1.19 7.31
MACD 0.75 0.75
Stochastic Oscillator 57.58 60.36

Price Performance

Historical Comparison
QURE
NHC

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

Share on Social Networks: